Spine Degenerative Conditions and Their Treatments: National Trends in the United States of America

Zorica Buser, Brandon Ortega, Anthony D'Oro, William Pannell, Jeremiah R Cohen, Justin Wang, Ray Golish, Michael Reed, Jeffrey C Wang, Zorica Buser, Brandon Ortega, Anthony D'Oro, William Pannell, Jeremiah R Cohen, Justin Wang, Ray Golish, Michael Reed, Jeffrey C Wang

Abstract

Study design: Retrospective database study.

Objective: Low back and neck pain are among the top leading causes of disability worldwide. The aim of our study was to report the current trends on spine degenerative disorders and their treatments.

Methods: Patients diagnosed with lumbar or cervical spine conditions within the orthopedic subset of Medicare and Humana databases (PearlDiver). From the initial cohorts we identified subgroups based on the treatment: fusion or nonoperative within 1 year from diagnosis. Poisson regression was used to determine demographic differences in diagnosis and treatment approaches.

Results: Within the Medicare database there were 6 206 578 patients diagnosed with lumbar and 3 156 215 patients diagnosed with cervical degenerative conditions between 2006 and 2012, representing a 16.5% (lumbar) decrease and 11% (cervical) increase in the number of diagnosed patients. There was an increase of 18.5% in the incidence of fusion among lumbar patients. For the Humana data sets there were 1 160 495 patients diagnosed with lumbar and 660 721 patients diagnosed with cervical degenerative disorders from 2008 to 2014. There was a 33% (lumbar) and 42% (cervical) increases in the number of diagnosed patients. However, in both lumbar and cervical groups there was a decrease in the number of surgical and nonoperative treatments.

Conclusions: There was an overall increase in both lumbar and cervical conditions, followed by an increase in lumbar fusion procedures within the Medicare database. There is still a burning need to optimize the spine care for the elderly and people in their prime work age to lessen the current national economic burden.

Keywords: Humana; Medicare; conservative treatment; database study; degenerative spine conditions; fusion; retrospective; trends.

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: ZB—Xenco Medical (consultancy), AO Spine (consultancy, past). JCW—Royalties: Aesculap, Biomet, Amedica, Seaspine, Synthes; Stock Ownership: Fziomed; Private Investments: Promethean Spine, Paradigm spine, Benevenue, NexGen, Vertiflex, electrocore, surgitech, expanding orthopaedics, osprey, bone biologics, curative biosciences, pearldiver; Board of Directors: North American Spine Society (non-financial, reimbursement for travel for board meetings, courses, etc.), North American Spine Foundation (non-financial), Cervical Spine Research Society (non-financial, reimbursement for travel for board meetings), AO Spine/AO Foundation (honorariums for board position); Fellowship Support: AO Foundation (spine fellowship funding paid to institution). RG-US Food and Drug Administration, Paid Consultant, 2010–2020. American Academy of Orthopaedic Surgeons, Chairman Biomedical Engineering Committee, 2016-2018. ASTM Intl., Co-Chairman F04.25 Spinal Devices Committee, 2016-present. Ziehm Imaging GmbH, Paid consultant, November 2016–present. Simplify Medical, Paid consultant, July 2016–present. icotec AG, Paid consultant, July 2016–present. Intrinsic Therapeutics, Paid consultant, June 2016–present. Medacta USA, Paid consultant, June 2016–present. Cytonics Inc., Unpaid consultant, Former paid consultant, Stockholder, January 2010–present.

References

    1. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743–800. doi:10.1016/S0140-6736(15)60692-4.
    1. Good CR, Auerbach JD, O’Leary PT, Schuler TC. Adult spine deformity. Curr Rev Musculoskelet Med. 2011;4:159–167. doi:10.1007/s12178-011-9101-z.
    1. Bono CM, Lee CK. Critical analysis of trends in fusion for degenerative disc disease over the past 20 years: influence of technique on fusion rate and clinical outcome. Spine (Phila Pa 1976). 2004;29:455–463.
    1. Deyo RA, Gray DT, Kreuter W, Mirza S, Martin BI. United States trends in lumbar fusion surgery for degenerative conditions. Spine (Phila Pa 1976). 2005;30:1441–1445.
    1. O'Lynnger TM, Zuckerman SL, Morone PJ, Dewan MC, Vasquez-Castellanos RA, Cheng JS. Trends for spine surgery for the elderly: implications for access to healthcare in North America. Neurosurgery. 2015;77(suppl 4):S136–S141.
    1. Taylor VM, Deyo RA, Cherkin DC, Kreuter W. Low back pain hospitalization. Recent United States trends and regional variations. Spine (Phila Pa 1976). 1994;19:1207–1212.
    1. Martin BI, Deyo RA, Mirza SK, et al. Expenditures and health status among adults with back and neck problems. JAMA. 2008;299:656–664. doi:10.1001/jama.299.6.656.
    1. Deyo RA, Mirza SK, Martin BI. Back pain prevalence and visit rates: estimates from U.S. national surveys, 2002. Spine (Phila Pa 1976). 2006;31:2724–2727.
    1. Weinstein JN, Lurie JD, Olson PR, Bronner KK, Fisher ES. United States’ trends and regional variations in lumbar spine surgery: 1992-2003. Spine (Phila Pa 1976). 2006;31:2707–2714.
    1. Terran J, McHugh BJ, Fischer CR, et al. Surgical treatment for adult spinal deformity: projected cost effectiveness at 5-year follow-up. Ochsner J. 2014;14:14–22.
    1. Cowan JA, Jr, Dimick JB, Wainess R, Upchurch GR, Jr, Chandler WF, La Marca F. Changes in the utilization of spinal fusion in the United States. Neurosurgery. 2006;59:15–20.
    1. Marawar S, Girardi FP, Sama AA, et al. National trends in anterior cervical fusion procedures. Spine (Phila Pa 1976). 2010;35:1454–1459.
    1. Carreon LY, Glassman SD, Howard J. Fusion and nonsurgical treatment for symptomatic lumbar degenerative disease: a systematic review of Oswestry Disability Index and MOS Short Form-36 outcomes. Spine J. 2008;8:747–755.
    1. Todd AG. Cervical spine: degenerative conditions. Curr Rev Musculoskelet Med. 2011;4:168–174.
    1. Epstien JA, Epstein WE. The surgical management of cervical spinal stenosis, spondylosis, and myeloradiculopathy by means of the posterior approach In: Benzel EC, ed. The Cervical Spine. Philadelphia, PA: JB Lippincott; 1989.
    1. Simotas AC, Dorey FJ, Hansraj KK, Cammisa F., Jr Nonoperative treatment for lumbar spinal stenosis. Clinical and outcome results and a 3-year survivorship analysis. Spine (Phila Pa 1976). 2000;25:197–203.
    1. Chassin MR. Explaining geographic variations. The enthusiasm hypothesis. Med Care. 1993;31(5 suppl):YS37–YS44.
    1. Irwin Z, Hilibrand A, Gustavel M, et al. Variations in surgical decision making for degenerative spinal disorders. Part I: lumbar spine. Spine (Phila Pa 1976). 2005;30:2208–2213.
    1. Angevine PD, Arons RR, McCormick PC. National and regional rates and variation of cervical discectomy with and without anterior fusion, 1990-1999. Spine (Phila Pa 1976). 2003;28:931–939.
    1. Yoshihara H, Yoneoka D. National trends in the surgical treatment for lumbar degenerative disc disease: United States, 2000 to 2009. Spine J. 2015;15:265–271. doi:0.1016/j.spinee.2014.09.026.
    1. Pannell WC, Savin DD, Scott TP, Wang JC, Daubs MD. Trends in the surgical treatment of lumbar spine disease in the United States. Spine J. 2015;15:1719–1727.
    1. Cook C, Santos GC, Lima R, Pietrobon R, Jacobs DO, Richardson W. Geographic variation in lumbar fusion for degenerative disorders: 1990 to 2000. Spine J. 2007;7:552–557.
    1. American Medical Association. Physician Characteristics and Distribution in the U.S. Chicago, IL: American Medical Association; 2012.
    1. Katz JN. Lumbar spinal fusion. Surgical rates, costs, and complications. Spine (Phila Pa 1976). 1995;20(24 suppl):78S–83S.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅